Spectral Diagnostics Inc. (OTCMKTS:EDTXF) Sees Large Growth in Short Interest

Spectral Diagnostics Inc. (OTCMKTS:EDTXF) was the recipient of a large increase in short interest during the month of October. As of October 15th, there was short interest totaling 12,731 shares, an increase of 147.6% from the September 30th total of 5,142 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 8,964 shares, the days-to-cover ratio is presently 1.4 days.

Spectral Diagnostics Price Performance

Shares of EDTXF traded up $0.06 during mid-day trading on Friday, reaching $0.72. The company had a trading volume of 1,235 shares, compared to its average volume of 10,148. Spectral Diagnostics has a twelve month low of $0.64 and a twelve month high of $1.10. The company has a market capitalization of $212.94 million, a P/E ratio of -7.23 and a beta of 0.14. The company’s 50-day moving average is $0.84 and its 200-day moving average is $0.95.

Spectral Diagnostics Company Profile

Spectral Diagnostics Inc is a Canadian medical technology company focused on improving the diagnosis and treatment of sepsis and septic shock. The company develops products designed to identify endotoxin activity, an important factor in certain severe infections and inflammatory conditions.

Its principal diagnostic product is the Endotoxin Activity Assay, a blood test intended to measure a patient’s level of endotoxin activity and help identify individuals who may be at increased risk of developing severe sepsis.